HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells. - Wikidata - awgldk - TriplyDB

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

http://www.wikidata.org/entity/Q36149317

about

Hallmarks of cancer and AU-rich elements The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial.HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells.Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells.Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer.GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.Elevated HuR in Pancreas Promotes a Pancreatitis-like Inflammatory Microenvironment that Facilitates Tumor Development.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.Complex HuR function in pancreatic cancer cells.Posttranscriptional Regulation of PARG mRNA by HuR Facilitates DNA Repair and Resistance to PARP Inhibitors.

P2860

Q26744134-67C2A565-DF52-4C8E-A398-62C056B87ACA Q26765247-7B18C228-3F04-404D-8BC4-ABBDA376BD35 Q28290458-E1B5CCBF-958D-49C5-A3D1-C9C2593DEA73 Q33727842-EFB1313E-CE47-4DBF-BC5A-A5D772F59F6F Q34404877-8D09EC17-E31C-4631-963F-62DBBA322152 Q34491276-0AC9AF1C-CF9E-4EA0-8695-67470D9F1E3E Q34494886-D008BCFA-E1EB-4601-8A5B-71A6CD8632BD Q34608366-28D45B30-4C1D-4DF2-8050-69DB5AD95D12 Q35982020-4D032603-BFC7-4845-8DD5-4F9B62D3FE15 Q37357373-F31C9321-9BDB-42F4-B15D-3C6A90E67ADC Q37687521-6AA00E08-6D54-4068-AEA5-567EB78E1D1D Q37701162-CD63987F-A64A-47C2-8188-496DFA9076BB Q38811283-B6FF078B-B951-4C64-B58F-53058037FE73 Q38924056-CFC402BE-658E-48A6-82E4-76878827B33E Q39133952-D2D58500-D0F3-44AC-B4EE-6D4503B04215 Q39602604-27218AE3-C984-4C34-8AFC-CC0DFCC67784 Q47407066-31C672AC-FE46-47B7-9D7C-66682921904D Q48820342-B0C7C443-8D83-4F8F-9E74-E56012EC669B Q49922188-A59D156C-5BCB-40ED-B5DC-3203641FB821 Q50902460-7475C052-E163-423F-A58B-7FD40FFC5E5D

P2860

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

http://www.wikidata.org/entity/Q36149317

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

@ast

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

@en

type

label

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

@ast

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

@en

prefLabel

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

@ast

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.

@en

P1433

Q36149317-1AA6CDFA-DC7A-4DC2-AF79-28FCAE76D83A

P1476

Q36149317-038A2333-ECAB-4742-80A2-8F1780DD92F3

P2093

Q36149317-1E090DE6-200A-4E46-8343-DD7A3E7ED4B1

Q36149317-2CE99000-6F62-4D7B-875B-2B856B96CD95

Q36149317-727DFF66-66A7-4441-ACC8-E018A3BE084F

Q36149317-846F5D69-9555-44C0-8A93-B46199CB98CE

Q36149317-8A0A16F5-5381-47C9-8B95-1F63677D98BE

Q36149317-8EC7313B-72C6-49A1-A3D8-4761BB264B44

Q36149317-94F3C2D1-C670-4953-BE9D-7EEEFA1CD908

Q36149317-987D1F04-B22A-4CA0-A52A-F1613DECE1BC

Q36149317-A987018C-2C73-48F3-877B-F4EA79D52C4D

Q36149317-B8AAB027-34E6-4C18-BE18-D6492426D399

P2860

Q36149317-0822B088-CD86-44EA-AC4F-54A13D82DCA2

Q36149317-0F3E31E0-71D1-4C0A-93E1-8DFBFE69C2CE

Q36149317-1A0E68FA-31FC-4EB9-8114-4FBACC692E7A

Q36149317-1A873315-0413-49EA-B240-17728804E1B1

Q36149317-1AFA0DAD-41ED-4063-BB9B-60AB3AA41F99

Q36149317-1B29D6BA-B7B2-4ADA-995F-B95205CCDA09

Q36149317-27FCD0B0-C99B-4263-991E-8662252EEF0D

Q36149317-2A0AD477-DA14-4D54-89FA-B528EC0388B3

Q36149317-492AD391-22E1-4D72-90FB-98441FAEF56E

Q36149317-49E8DD44-0CF4-460B-9166-88120699E3D4

P304

Q36149317-AE6E68DA-5F14-438F-ABFF-1A8B9D73BBEE

P31

Q36149317-215BA3F7-AF23-4530-ACD0-87740B2E0C89

P356

Q36149317-08FE5FE4-9FEB-4247-943E-0DFB97BA80FC

P433

Q36149317-43E0F00B-16F5-4D82-B4B2-D6A437F6EF8B

P478

Q36149317-EA1DDFF4-6ADB-4E2E-8EA5-B17CA9E0655E

P50

Q36149317-40AF5F83-AD5A-4BE7-B5AA-119558AB3C5E

Q36149317-8B01F5D2-035B-4A81-B952-064E1E81F59E

P577

Q36149317-54D9B494-128D-4018-8251-A9D65224370A

P698

Q36149317-BFC82F80-4D7B-4593-948E-F4B39BA9DEBE

P932

Q36149317-6F173408-60F5-4A4A-87A1-3EC767B7DAC8

P356

P1433

Cancer Biology and Therapy

P1476

HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells

@en

P2093

Agnieska K Witkiewicz

http://www.w3.org/2001/XMLSchema#string

Benjamin Leiby

http://www.w3.org/2001/XMLSchema#string

Charles J Yeo

http://www.w3.org/2001/XMLSchema#string

Christopher C Valley

http://www.w3.org/2001/XMLSchema#string

Danielle M Pineda

http://www.w3.org/2001/XMLSchema#string

David W Rittenhouse

http://www.w3.org/2001/XMLSchema#string

Jonathan N Sachs

http://www.w3.org/2001/XMLSchema#string

Jonathan R Brody

http://www.w3.org/2001/XMLSchema#string

Jordan M Winter

http://www.w3.org/2001/XMLSchema#string

Joseph A Cozzitorto

http://www.w3.org/2001/XMLSchema#string

P2860

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

HuR regulates p21 mRNA stabilization by UV light

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Fast and accurate short read alignment with Burrows-Wheeler transform

The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

Posttranscriptional regulation of cancer traits by HuR

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

P304

946-955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.20952

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Isidore Rigoutsos

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22785201

http://www.w3.org/2001/XMLSchema#string

P932

3414415

http://www.w3.org/2001/XMLSchema#string